Related Experiment Videos

Rhabdomyolysis in association with Duchenne's muscular dystrophy

R Obata1, Y Yasumi, A Suzuki

  • 1Department of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, Japan.

Insights

Sevoflurane anesthesia may trigger rhabdomyolysis in children with Duchenne muscular dystrophy. This case highlights a potential risk, suggesting caution when using sevoflurane in these patients.

Area of Science:

  • Anesthesiology
  • Pediatric Neurology
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) is a genetic disorder causing progressive muscle degeneration.
  • Anesthetic agents require careful selection in patients with neuromuscular disorders due to potential complications.
  • Rhabdomyolysis, the breakdown of muscle tissue, can lead to serious health issues.

Observation:

  • An 11-year-old boy with a known diagnosis of Duchenne muscular dystrophy underwent anesthesia for strabismus repair.
  • The anesthetic regimen included sevoflurane and nitrous oxide, without muscle relaxants.
  • Postoperatively, the patient developed heel pain and myoglobinuria, indicative of rhabdomyolysis.

Findings:

  • This case presents the first reported instance of sevoflurane-induced rhabdomyolysis in a child with Duchenne muscular dystrophy.
  • The patient responded to dantrolene sodium treatment and was discharged without further complications.
  • The development of rhabdomyolysis suggests a potential adverse reaction to sevoflurane in this specific patient population.

Implications:

  • The findings question the safety of sevoflurane in pediatric patients with Duchenne muscular dystrophy.
  • Further investigation is warranted to understand the mechanism and prevalence of this adverse event.
  • Anesthesiologists should consider alternative anesthetic agents or exercise extreme caution when sevoflurane is administered to children with DMD.
Abstract

Related Concept Videos